Download PDF
Journal of Pediatric Epilepsy 2021; 10(01): 013-021
DOI: 10.1055/s-0040-1718723
Original Article

Electroencephalographic Findings in Pediatric Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis: The San Diego Experience

Aliya Frederick
1   Division of Child Neurology, University of California San Diego and Rady Children's Hospital, San Diego, California, United States
2   Department of Neurology, University of California San Diego, San Diego, California, United States
,
Jennifer H. Yang
1   Division of Child Neurology, University of California San Diego and Rady Children's Hospital, San Diego, California, United States
2   Department of Neurology, University of California San Diego, San Diego, California, United States
,
Natalie Guido-Estrada
1   Division of Child Neurology, University of California San Diego and Rady Children's Hospital, San Diego, California, United States
2   Department of Neurology, University of California San Diego, San Diego, California, United States
,
Jose Soria-Lopez
2   Department of Neurology, University of California San Diego, San Diego, California, United States
,
Shifteh Sattar
1   Division of Child Neurology, University of California San Diego and Rady Children's Hospital, San Diego, California, United States
2   Department of Neurology, University of California San Diego, San Diego, California, United States
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Diagnosing anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis clinically can be challenging. There is a growing interest in identifying specific electroencephalographic features to help guide early management. A retrospective chart review was conducted of pediatric patients admitted to Rady Children's Hospital between January 1, 2010 and April 1, 2017. We included patients with the diagnosis of encephalitis who underwent continuous video electroencephalogram (VEEG) for at least 12 hours, and presented with less than 14 days of symptoms. We compared the electroencephalographic features of non-rapid eye movement (NREM) sleep between patients with antibody confirmed anti-NMDAR encephalitis and patients with encephalitis from other etiologies. We identified seven patients who met our inclusion criteria, five of whom were diagnosed with anti-NMDAR encephalitis. Four of the five patients had a significant reduction in NREM sleep, while one patient had increased NREM sleep associated with clinical catatonia and hypersomnolence. Sleep was preserved in the two cases of nonimmune mediated encephalitis. Our results suggest that a prolonged VEEG to capture sleep coupled with clinical features can aid in early diagnosis and treatment of anti-NMDAR encephalitis, often before confirmatory antibody testing is available.

Keywords

anti-NMDA receptor encephalitis - anti-NMDAR encephalitis - electroencephalogram - NREM sleep


Publication History

Received: 08 July 2020

Accepted: 10 September 2020

Article published online:
02 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Dalmau J, Bataller L. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications]. Neurologia 2007; 22 (08) 526-537
    PubMedGoogle Scholar
  • 2 Rosenfeld MR, Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol 2011; 13 (03) 324-332
    CrossrefPubMedGoogle Scholar
  • 3 Florance NR, Davis RL, Lam C. et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66 (01) 11-18
    CrossrefPubMedGoogle Scholar
  • 4 Florance-Ryan N, Dalmau J. Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr 2010; 22 (06) 739-744
    CrossrefPubMedGoogle Scholar
  • 5 Brenton JN, Kim J, Schwartz RH, Schwartz RH. Approach to the management of pediatric-onset anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis: a case series. J Child Neurol 2016; 31 (09) 1150-1155
    CrossrefPubMedGoogle Scholar
  • 6 Armangue T, Titulaer MJ, Málaga I. Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group. et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013; 162 (04) 850-856.e2
    CrossrefPubMedGoogle Scholar
  • 7 Dalmau J, Gleichman AJ, Hughes EG. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
    CrossrefPubMedGoogle Scholar
  • 8 Titulaer MJ, McCracken L, Gabilondo I. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 9 Nosadini M, Boniver C, Zuliani L. et al. Longitudinal electroencephalographic (EEG) findings in pediatric anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis: the Padua experience. J Child Neurol 2015; 30 (02) 238-245
    CrossrefPubMedGoogle Scholar
  • 10 Sands TT, Nash K, Tong S, Sullivan J. Focal seizures in children with anti-NMDA receptor antibody encephalitis. Epilepsy Res 2015; 112: 31-36
    CrossrefPubMedGoogle Scholar
  • 11 Sonderen AV, Arends S, Tavy DLJ. et al. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2018; 89 (10) 1101-1106
    CrossrefPubMedGoogle Scholar
  • 12 Zhang Y, Liu G, Jiang MD, Li LP, Su YY. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol 2017; 128 (07) 1227-1233
    CrossrefPubMedGoogle Scholar
  • 13 Haberlandt E, Ensslen M, Gruber-Sedlmayr U. et al. Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis. Eur J Paediatr Neurol 2017; 21 (03) 457-464
    CrossrefPubMedGoogle Scholar
  • 14 Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012; 79 (11) 1094-1100
    CrossrefPubMedGoogle Scholar
  • 15 Jeannin-Mayer S, André-Obadia N, Rosenberg S. et al. EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol 2019; 130 (02) 289-296
    CrossrefPubMedGoogle Scholar
  • 16 Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011; 20 (02) 392-394
    CrossrefPubMedGoogle Scholar
  • 17 Mohammad SS, Soe SM, Pillai SC. et al. Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis. Clin Neurophysiol 2016; 127 (10) 3217-3224
    CrossrefPubMedGoogle Scholar
  • 18 da Silva-Júnior FP, Castro LH, Andrade JQ. et al. Serial and prolonged EEG monitoring in anti-N-Methyl-d-Aspartate receptor encephalitis. Clin Neurophysiol 2014; 125 (08) 1541-1544
    CrossrefPubMedGoogle Scholar
  • 19 Gitiaux C, Simonnet H, Eisermann M. et al. Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children. Clin Neurophysiol 2013; 124 (12) 2354-2361
    CrossrefPubMedGoogle Scholar
  • 20 Baysal-Kirac L, Tuzun E, Altindag E. et al. Are there any specific EEG findings in autoimmune epilepsies?. Clin EEG Neurosci 2016; 47 (03) 224-234
    CrossrefPubMedGoogle Scholar
  • 21 Freund B, Ritzl EK. A review of EEG in anti-NMDA receptor encephalitis. J Neuroimmunol 2019; 332: 64-68
    CrossrefPubMedGoogle Scholar
  • 22 Gillinder L, Warren N, Hartel G, Dionisio S, O'Gorman C. EEG findings in NMDA encephalitis - A systematic review. Seizure 2019; 65: 20-24
    CrossrefPubMedGoogle Scholar
  • 23 Ariño H, Muñoz-Lopetegi A, Martinez-Hernandez E. et al. Sleep disorders in anti-NMDAR encephalitis. Neurology 2020; 95 (06) e671-e684
    CrossrefPubMedGoogle Scholar
  • 24 Kahn A, Dan B, Groswasser J, Franco P, Sottiaux M. Normal sleep architecture in infants and children. J Clin Neurophysiol 1996; 13 (03) 184-197
    CrossrefPubMedGoogle Scholar
  • 25 Burgdorf JS, Vitaterna MH, Olker CJ. et al. NMDAR activation regulates the daily rhythms of sleep and mood. Sleep (Basel) 2019;42(10):
    PubMedGoogle Scholar
  • 26 Campbell IG, Gustafson LM, Feinberg I. The competitive NMDA receptor antagonist CPPene stimulates NREM sleep and eating in rats. Neuropsychopharmacology 2002; 26 (03) 348-357
    CrossrefPubMedGoogle Scholar
  • 27 Kopp C, Longordo F, Nicholson JR, Lüthi A. Insufficient sleep reversibly alters bidirectional synaptic plasticity and NMDA receptor function. J Neurosci 2006; 26 (48) 12456-12465
    CrossrefPubMedGoogle Scholar
  • 28 Chen C, Hardy M, Zhang J, LaHoste GJ, Bazan NG. Altered NMDA receptor trafficking contributes to sleep deprivation-induced hippocampal synaptic and cognitive impairments. Biochem Biophys Res Commun 2006; 340 (02) 435-440
    CrossrefPubMedGoogle Scholar
  • 29 Hughes EG, Peng X, Gleichman AJ. et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30 (17) 5866-5875
    CrossrefPubMedGoogle Scholar
  • 30 Ang G, McKillop LE, Purple R. et al. Absent sleep EEG spindle activity in GluA1 (Gria1) knockout mice: relevance to neuropsychiatric disorders. Transl Psychiatry 2018; 8 (01) 154
    CrossrefPubMedGoogle Scholar
  • 31 Yasuda K, Hayashi Y, Yoshida T. et al. Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults. Transl Psychiatry 2017; 7 (02) e1047
    CrossrefPubMedGoogle Scholar
  • 32 Nakazawa K, Jeevakumar V, Nakao K. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia. NPJ Schizophr 2017; 3: 7
    CrossrefPubMedGoogle Scholar